Beijing Chunlizhengda Medical Instruments Co., Ltd. (688236.SS)
CNY 14.4
(4.35%)
CNY 14.4
(4.35%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 686.53 Million CNY | -0.51% |
| 2022 | 690.06 Million CNY | 30.06% |
| 2021 | 530.57 Million CNY | 15.24% |
| 2020 | 460.4 Million CNY | 14.32% |
| 2019 | 402.72 Million CNY | 115.82% |
| 2018 | 186.6 Million CNY | 96.03% |
| 2017 | 95.18 Million CNY | 60.74% |
| 2016 | 59.21 Million CNY | 8.69% |
| 2015 | 54.48 Million CNY | 60.56% |
| 2014 | 33.93 Million CNY | 63.59% |
| 2013 | 20.74 Million CNY | 44.66% |
| 2012 | 14.34 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 608.37 Million CNY | -11.38% |
| 2024 Q2 | 813.56 Million CNY | 33.73% |
| 2024 Q3 | 698.38 Million CNY | -14.16% |
| 2023 Q3 | 577.99 Million CNY | -22.42% |
| 2023 Q1 | 615.41 Million CNY | -10.82% |
| 2023 Q2 | 745.05 Million CNY | 21.07% |
| 2023 FY | 686.53 Million CNY | -0.51% |
| 2023 Q4 | 686.53 Million CNY | 18.78% |
| 2022 Q4 | 690.06 Million CNY | 41.41% |
| 2022 Q2 | 530.79 Million CNY | 6.79% |
| 2022 FY | 690.06 Million CNY | 30.06% |
| 2022 Q1 | 497.05 Million CNY | -6.32% |
| 2022 Q3 | 487.98 Million CNY | -8.07% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 FY | 530.57 Million CNY | 15.24% |
| 2021 Q4 | 530.57 Million CNY | 0.0% |
| 2021 Q2 | 412.53 Million CNY | 0.0% |
| 2020 Q4 | 460.4 Million CNY | -0.4% |
| 2020 FY | 460.4 Million CNY | 14.32% |
| 2020 Q2 | 357.02 Million CNY | 0.0% |
| 2020 Q3 | 462.25 Million CNY | 29.48% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q3 | 311.05 Million CNY | 17.59% |
| 2019 Q1 | 245.54 Million CNY | 31.59% |
| 2019 Q2 | 264.53 Million CNY | 7.73% |
| 2019 FY | 402.72 Million CNY | 115.82% |
| 2019 Q4 | 402.72 Million CNY | 29.47% |
| 2018 Q4 | 186.6 Million CNY | 8.45% |
| 2018 Q2 | 141.96 Million CNY | 29.26% |
| 2018 Q1 | 109.83 Million CNY | 15.38% |
| 2018 Q3 | 172.06 Million CNY | 21.2% |
| 2018 FY | 186.6 Million CNY | 96.03% |
| 2017 Q1 | 58.07 Million CNY | -1.92% |
| 2017 Q4 | 95.18 Million CNY | 22.64% |
| 2017 FY | 95.18 Million CNY | 60.74% |
| 2017 Q3 | 77.61 Million CNY | 4.06% |
| 2017 Q2 | 74.59 Million CNY | 28.43% |
| 2016 FY | 59.21 Million CNY | 8.69% |
| 2016 Q2 | 66.17 Million CNY | 41.19% |
| 2016 Q1 | 46.86 Million CNY | -13.98% |
| 2016 Q3 | 41.99 Million CNY | -36.54% |
| 2016 Q4 | 59.21 Million CNY | 41.03% |
| 2015 Q4 | 54.48 Million CNY | 44.7% |
| 2015 Q2 | 58.93 Million CNY | 40.22% |
| 2015 Q3 | 37.65 Million CNY | -36.11% |
| 2015 FY | 54.48 Million CNY | 60.56% |
| 2015 Q1 | 42.02 Million CNY | 23.84% |
| 2014 FY | 33.93 Million CNY | 63.59% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 Q4 | 33.93 Million CNY | 0.0% |
| 2013 FY | 20.74 Million CNY | 44.66% |
| 2013 Q4 | 15.07 Million CNY | 0.0% |
| 2012 FY | 14.34 Million CNY | 0.0% |